IB SETTLEMENT(00147)
Search documents
ST香雪(300147.SZ):产品香雪抗病毒口服液具有清热祛湿,凉血解毒功效
Ge Long Hui· 2025-11-14 07:14
Core Viewpoint - ST Xiangxue's product, Xiangxue Anti-Virus Oral Liquid, is widely used in clinical settings for treating various ailments, including colds, influenza, upper respiratory infections, mumps, viral conjunctivitis, and hand-foot-mouth disease, and has played a significant role during outbreaks of SARS, H1N1 influenza, and avian influenza [1] Group 1 - The product has functions such as clearing heat and dampness, cooling blood, and detoxifying [1] - It is clinically recognized for its effectiveness in treating respiratory infections and other viral diseases [1] - The company emphasizes the historical importance of its product in combating major viral outbreaks [1]
港股国际商业结算盘中涨近4%
Mei Ri Jing Ji Xin Wen· 2025-11-11 02:50
Group 1 - The stock of International Commercial Settlement (00147.HK) in Hong Kong experienced a nearly 4% increase during trading, with a current rise of 3.85% to HKD 0.27 [1] - The trading volume reached HKD 6.1284 million [1]
港股异动 | 国际商业结算(00147)盘中涨近4% 附属与Sharpening Technology订立战略合作框架协议
智通财经网· 2025-11-11 02:36
Group 1 - International Commercial Settlement's stock increased by nearly 4%, closing at 0.27 HKD with a trading volume of 6.1284 million HKD [1] - The company announced a strategic cooperation framework agreement with Sharpening Technology, effective from November 10, 2025, for a duration of one year, with a total service amount not exceeding 100 million USD (approximately 780 million HKD) [1] - Keen Golden, a non-wholly owned subsidiary of the company, signed its first cloud computing service agreement with Sharpening Technology, agreeing to procure cloud mining services with a minimum power of 1 EH/s for a cost of 15 million USD (approximately 117 million HKD) [1] Group 2 - Between October 17, 2025, and November 7, 2025, the group acquired approximately 247.8694 bitcoins in the open market for a total cost of about 25.7 million USD (approximately 200 million HKD) [2] - The average purchase price for the bitcoins was approximately 103.7 thousand USD (around 806.9 thousand HKD) per bitcoin [2]
国际商业结算(00147.HK)附属Keen Golden与Sharpening Technology订立战略合作框架协议
Sou Hu Cai Jing· 2025-11-10 13:36
Group 1 - The core point of the article is the strategic cooperation framework agreement between International Commercial Settlement (00147.HK) and Sharpening Technology, which will provide cloud computing mining services valued at up to $100 million (approximately 780 million HKD) starting from November 10, 2025 [1] - The agreement is set for a duration of one year, with formal cloud computing service agreements to be established following negotiations on procurement terms [1] - As of the market close on November 10, 2025, International Commercial Settlement's stock price was HKD 0.26, reflecting a 4.42% increase with a trading volume of 22.145 million shares and a turnover of HKD 5.7793 million [1] Group 2 - International Commercial Settlement has a market capitalization of HKD 5.752 billion and ranks 44th in the real estate development II industry [1] - There has been low attention from investment banks regarding this stock, with no ratings provided in the past 90 days [1]
国际商业结算(00147)附属Keen Golden与Sharpening Technology订立战略合作框架协议
智通财经网· 2025-11-10 13:33
Core Viewpoint - International Business Settlement (00147) has entered into a strategic cooperation framework agreement with Sharpening Technology for cloud computing mining services, with a total service amount not exceeding $100 million (approximately HKD 780 million) [1] Group 1: Strategic Cooperation Agreement - The strategic cooperation framework agreement is effective from November 10, 2025, for a duration of one year [1] - Keen Golden, a non-wholly owned subsidiary of the company, will procure cloud computing mining services from Sharpening Technology [1] Group 2: Cloud Computing Mining Service Agreement - A cloud computing service agreement has been established, where Keen Golden agrees to purchase mining power of at least 1 EH/s for a period of 365 days, at a cost of $15 million (approximately HKD 117 million) in Bitcoin [1] - The payment for this service will be made by transferring 146.7 Bitcoins to Sharpening Technology at the reference price [2] Group 3: Bitcoin Acquisition - Between October 17, 2025, and November 7, 2025, the group acquired approximately 247.8694 Bitcoins in the open market for a total cost of about $25.7 million (approximately HKD 200 million), at an average price of about $103,700 per Bitcoin (approximately HKD 806,900) [1]
国际商业结算附属Keen Golden与Sharpening Technology订立战略合作框架协议
Zhi Tong Cai Jing· 2025-11-10 13:28
Group 1 - The company International Commercial Settlement (00147) announced a strategic cooperation framework agreement with Sharpening Technology, effective from November 10, 2025, for a duration of one year, with a total service amount not exceeding $100 million (approximately HKD 780 million) [1] - Keen Golden, a non-wholly owned subsidiary of the company, entered into its first cloud computing service agreement with Sharpening Technology, agreeing to procure cloud mining services with a minimum power of 1 EH/s for a period of 365 days, at a cost of $15 million (approximately HKD 117 million) in Bitcoin [1] - Between October 17, 2025, and November 7, 2025, the group acquired approximately 247.8694 Bitcoins in the open market for a total cost of about $25.7 million (approximately HKD 200 million), at an average price of about $103,700 (approximately HKD 806,900) per Bitcoin [1] Group 2 - On November 10, 2025, under the cloud computing service agreement, Keen Golden transferred 146.7 Bitcoins to Sharpening Technology as payment for the $15 million (approximately HKD 117 million) service fee [2]
国际商业结算(00147.HK)附属向SharpeningTechnology采购云算力挖矿服务
Ge Long Hui· 2025-11-10 13:23
Core Viewpoint - The company has entered into a strategic cooperation framework agreement with Sharpening Technology to provide cloud computing mining services, with a total service amount not exceeding $100 million [1] Group 1: Strategic Agreements - Keen Golden, a non-wholly owned subsidiary of the company, signed a strategic cooperation framework agreement with Sharpening Technology effective from November 10, 2025, for a duration of one year [1] - The first cloud computing service agreement was also established, where Keen Golden agreed to purchase cloud mining services with a minimum computing power of 1 EH/s for a period of 365 days, at a cost of $15 million worth of Bitcoin [1] Group 2: Bitcoin Transactions - The company announced the acquisition of approximately 247.8694 Bitcoins in the open market for a total cost of about $25.7 million, averaging approximately $103,748.3 per Bitcoin between October 17, 2025, and November 7, 2025 [1] - As per the cloud computing service agreement, Keen Golden transferred 146.7 Bitcoins to Sharpening Technology as payment for the $15 million service fee [2]
国际商业结算(00147) - (1)有关採购云挖矿服务之自愿性公佈;及(2)有关收购及出售比特币之...
2025-11-10 13:14
INTERNATIONAL BUSINESS SETTLEMENT HOLDINGS LIMITED 國際商業結算控股有限公 司 (於百慕達註冊成立之有限公司) (股份代號:00147) (1)有關採購雲挖礦服務之自願性公佈;及 (2)有關收購及出售比特幣之須予披露交易 採購雲挖礦服務 於二零二五年十一月十日(交易時段後),本公司之非全資附屬公司Keen Golden與Sharpening Technology訂立戰略合作框架協議,協議自二零二五年十一月十日起為期一年。根據戰 略合作框架協議,Sharpening Technology將提供雲算力挖礦服務,服務金額合計不超過 100,000,000美元(相當於約780,000,000港元)。訂約各方應就各項採購協商條款並另行訂立 正式的雲算力服務協議。 同日,Keen Golden與Sharpening Technology訂立首份雲算力服務協議。根據雲算力服務協 議,Keen Golden同意採購及Sharpening Technology同意提供算力為至少1 EH/s的雲挖礦服 務,協議年期為365天,代價為價值15,000,000美元(相當於約117,0 ...
国际商业结算(00147) - 截至二零二五年十月三十一日之股份发行人的证券变动月报表
2025-11-06 03:52
FF301 公司名稱: 國際商業結算控股有限公司 (於百慕達註冊成立之有限公司) 呈交日期: 2025年11月6日 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致:香港交易及結算所有限公司 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00147 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 498,000,000,000 | HKD | | 0.001 | HKD | | 498,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 498,000,000,000 | HKD | | 0.001 ...
ST香雪(300147.SZ):TAEST16001注射液获得了晚期食管癌和晚期非小细胞肺癌的临床许可
Ge Long Hui· 2025-11-03 16:03
Core Viewpoint - ST Xiangxue's subsidiary is advancing its drug development pipeline with two new drugs, TAEST16001 and TAEST1901, targeting various cancers, indicating a strong focus on oncology research and potential market opportunities [1] Drug Development Progress - TAEST16001 injection is currently undergoing confirmatory clinical trials for the treatment of advanced soft tissue sarcoma [1] - TAEST1901 injection is in Phase I clinical research for advanced liver cancer [1] - TAEST16001 has also received clinical approval for advanced esophageal cancer and advanced non-small cell lung cancer [1] - TAEST1901 has obtained clinical approval for advanced gastric cancer [1]